Cargando…
Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
Epilepsy contributes to approximately 1% of the global disease burden. By affecting especially young children as well as older persons of all social and racial variety, epilepsy is a present disorder worldwide. Currently, only 65% of epileptic patients can be successfully treated with antiepileptic...
Autores principales: | Senn, Lara, Cannazza, Giuseppe, Biagini, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463541/ https://www.ncbi.nlm.nih.gov/pubmed/32751761 http://dx.doi.org/10.3390/ph13080174 |
Ejemplares similares
-
Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
por: Costa, Anna-Maria, et al.
Publicado: (2022) -
Antibacterial Effects of Phytocannabinoids
por: Scott, Cassidy, et al.
Publicado: (2022) -
Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances
por: Farrelly, Aaron M., et al.
Publicado: (2021) -
Oxidative Stress and Multi-Organel Damage Induced by Two Novel Phytocannabinoids, CBDB and CBDP, in Breast Cancer Cells
por: Salbini, Maria, et al.
Publicado: (2021) -
Phytocannabinoids in the Pharmacotherapy of Psoriasis
por: Wroński, Adam, et al.
Publicado: (2023)